Filing Details

Accession Number:
0001209191-18-050120
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-09-07 17:42:55
Reporting Period:
2018-09-05
Accepted Time:
2018-09-07 17:42:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600132 Bellerophon Therapeutics Inc. BLPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277997 P L Iv Associates Venrock C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1698082 P Nimish Shah C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1738048 Venrock Healthcare Capital Partners Iii, L.p. C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1738053 Vhcp Management Iii, Llc C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1750761 Vhcp Co-Investment Holdings Iii, Llc C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-09-05 50,000 $0.85 6,591,163 No 4 P Indirect By funds
Common Stock Acquisiton 2018-09-06 50,000 $0.84 6,641,163 No 4 P Indirect By funds
Common Stock Acquisiton 2018-09-07 60,000 $0.90 6,701,163 No 4 P Indirect By funds
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By funds
No 4 P Indirect By funds
No 4 P Indirect By funds
Footnotes
  1. This Form 4 is the second of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co Investment Holdings II, LLC, Venrock Healthcare Capital Partners III, LP, VHCP Management III, LLC, VHCP Co Investment Holdings III, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons.
  2. Consists of (i) 45,455 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 4,545 shares purchased by VHCP Co-Investment Holdings III, LLC.
  3. Consists of (i) 54,546 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 5,454 shares purchased by VHCP Co-Investment Holdings III, LLC.